Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
Malnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/14/3439 |
_version_ | 1797407117474267136 |
---|---|
author | Manon Gouez Lidia Delrieu Carole Bouleuc Nicolas Girard Bruno Raynard Timothée Marchal |
author_facet | Manon Gouez Lidia Delrieu Carole Bouleuc Nicolas Girard Bruno Raynard Timothée Marchal |
author_sort | Manon Gouez |
collection | DOAJ |
description | Malnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data were reported at 2 months (M2) and 4 months (M4) after the initiation of immunotherapy (M0). The influence of nutritional status at M0 was estimated with the efficacy and toxicity of immunotherapy at M2 to M4. In total, 127 patients were included in the study, and nutritional status was estimated at M0 for 120 patients: 67% were not malnourished, 20% presented with moderate malnutrition, and 13% presented with severe malnutrition. There was no significant link between the nutritional status at M0 and the toxicity of immunotherapy at M2 and M4. However, severe malnutrition was significantly associated with treatment efficacy at M2 (<i>p</i> = 0.04) and with a lower survival rate with an HR (Hazard Ratio) = 2.32–95% C.I: 1.13–4.75 (<i>p</i> = 0.02). Furthermore, a monthly decrease of 1% of the weight had an HR = 1.17–95% C.I: 1.13–1.21 (<i>p</i> = 0.0001). Severe malnutrition and weight loss are independent factors associated with lower survival. Studies integrating the systemic detection of sarcopenia with a closer nutritional follow-up could highlight an improvement in survival. |
first_indexed | 2024-03-09T03:36:38Z |
format | Article |
id | doaj.art-9241f9e9c3574990ae80780c93469d49 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-09T03:36:38Z |
publishDate | 2022-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-9241f9e9c3574990ae80780c93469d492023-12-03T14:47:44ZengMDPI AGCancers2072-66942022-07-011414343910.3390/cancers14143439Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French StudyManon Gouez0Lidia Delrieu1Carole Bouleuc2Nicolas Girard3Bruno Raynard4Timothée Marchal5Department of Prevention Cancer Environment, Léon Bérard Cancer Centre, 69008 Lyon, FranceResidual Tumour & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, FranceDepartment of Supportive Care, Institut Curie, 75005 Paris, FranceInstitut Curie, Institut du Thorax Curie Montsouris, 75005 Paris, FranceDepartment of Supportive Care, Unité Transversale de Diététique et de Nutrition Centre Gustave-Roussy, 94800 Villejuif, FranceDepartment of Supportive Care, Institut Curie, 75005 Paris, FranceMalnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data were reported at 2 months (M2) and 4 months (M4) after the initiation of immunotherapy (M0). The influence of nutritional status at M0 was estimated with the efficacy and toxicity of immunotherapy at M2 to M4. In total, 127 patients were included in the study, and nutritional status was estimated at M0 for 120 patients: 67% were not malnourished, 20% presented with moderate malnutrition, and 13% presented with severe malnutrition. There was no significant link between the nutritional status at M0 and the toxicity of immunotherapy at M2 and M4. However, severe malnutrition was significantly associated with treatment efficacy at M2 (<i>p</i> = 0.04) and with a lower survival rate with an HR (Hazard Ratio) = 2.32–95% C.I: 1.13–4.75 (<i>p</i> = 0.02). Furthermore, a monthly decrease of 1% of the weight had an HR = 1.17–95% C.I: 1.13–1.21 (<i>p</i> = 0.0001). Severe malnutrition and weight loss are independent factors associated with lower survival. Studies integrating the systemic detection of sarcopenia with a closer nutritional follow-up could highlight an improvement in survival.https://www.mdpi.com/2072-6694/14/14/3439advanced cancerimmunotherapylung cancernutritional statussurvival |
spellingShingle | Manon Gouez Lidia Delrieu Carole Bouleuc Nicolas Girard Bruno Raynard Timothée Marchal Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study Cancers advanced cancer immunotherapy lung cancer nutritional status survival |
title | Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study |
title_full | Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study |
title_fullStr | Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study |
title_full_unstemmed | Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study |
title_short | Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study |
title_sort | association between nutritional status and treatment response and survival in patients treated with immunotherapy for lung cancer a retrospective french study |
topic | advanced cancer immunotherapy lung cancer nutritional status survival |
url | https://www.mdpi.com/2072-6694/14/14/3439 |
work_keys_str_mv | AT manongouez associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy AT lidiadelrieu associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy AT carolebouleuc associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy AT nicolasgirard associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy AT brunoraynard associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy AT timotheemarchal associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy |